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BACKGROUND: Both the Centers for Medicare and Medicaid Services’ (CMS) Hospital Compare star rating and surgical case volume
have been publicized as metrics that can help patients to identify high-quality hospitals for complex care such as cancer surgery. The
current study evaluates the relationship between the CMS’ star rating, surgical volume, and short-term outcomes after major cancer
surgery. METHODS: National Medicare data were used to evaluate the relationship between hospital star ratings and cancer surgery
volume quintiles. Then, multilevel logistic regression models were fit to examine the association between cancer surgery outcomes
and both star rankings and surgical volumes. Lastly, a graphical approach was used to compare how well star ratings and surgical vol-
ume predicted cancer surgery outcomes. RESULTS: This study identified 365,752 patients undergoing major cancer surgery for 1 of 9
cancer types at 2,550 hospitals. Star rating was not associated with surgical volume (P<.001). However, both the star rating and sur-
gical volume were correlated with 4 short-term cancer surgery outcomes (mortality, complication rate, readmissions, and prolonged
length of stay). The adjusted predicted probabilities for 5- and 1-star hospitals were 2.3% and 4.5% for mortality, 39% and 48% for
complications, 10% and 15% for readmissions, and 8% and 16% for a prolonged length of stay, respectively. The adjusted predicted
probabilities for hospitals with the highest and lowest quintile cancer surgery volumes were 2.7% and 5.8% for mortality, 41% and 55%
for complications, 12.2% and 11.6% for readmissions, and 9.4% and 13% for a prolonged length of stay, respectively. Furthermore, surgi-
cal volume and the star rating were similarly associated with mortality and complications, whereas the star rating was more highly
associated with readmissions and prolonged length of stay. CONCLUSIONS: In the absence of other information, these findings sug-
gest that the star rating may be useful to patients when they are selecting a hospital for major cancer surgery. However, more
research is needed before these ratings can supplant surgical volume as a measure of surgical quality. Cancer 2017;123:4259-67.
VC 2017 American Cancer Society.
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INTRODUCTION
Selecting a hospital for cancer surgery is challenging. Likewise, the best way for patients to determine where to obtain
hospital-based health care remains a topic of debate in both the lay press and the scientific literature.1-4 In an attempt to
help patients make such decisions, several private and public organizations have released rating guides that rank hospitals
according to various measures of quality and safety.5-7
The newest measure in this area is the Centers for Medicare and Medicaid Services’ (CMS) Hospital Compare star
rating system. This program uses a complex methodology, based on a hospital’s performance with mortality, safety, read-
missions, patient experience, care effectiveness, care timeliness, and efficient use of medical imaging, to assign each hospi-
tal a star rating ranging from 1 (lowest score) to 5 (highest score). The stated goal for this program is “to help millions of
patients and their families learn about the quality of hospitals, compare facilities in their area side-by-side, and ask impor-
tant questions about care quality when visiting a hospital or other health care provider.”8 Although the star ratings have
the benefit of being publically available, the system has been criticized by some as being inaccurate, and there is little
empirical information that validates the relationship between star ratings and important patient outcomes, including those
of major cancer surgery.9
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In contrast, arguably the best structural measure of
quality for major cancer surgery is surgical case volume.
Illustrating this point, several prominent health systems
have issued a volume pledge for select surgical procedures,
including some major cancer operations, as a way of dem-
onstrating their commitment to transparency and high-
quality care.10 For the most part, however, the impact of
this metric remains limited by the fact that hospital surgical
volumes are not routinely available to the public.
In this context, an important question is whether a
hospital’s annual surgical volume correlates strongly with
its Hospital Compare star rating for major cancer surgery.
Furthermore, it is unknown whether one of these mea-
sures more strongly predicts important patient outcomes.
The availability of such data would not only clarify the rel-
evance of the star rating system for patients in need of
major cancer surgery but also provide a better sense of its
potential value as a quality metric for a broader range of
conditions. Accordingly, we used data from the Hospital
Compare program and national Medicare claims to evalu-
ate the relationship between the CMS star rating and sur-
gical volume for hospitals performing major cancer
surgery. We also examined the frequency of short-term
adverse outcomes with respect to star ratings and surgical
volumes, and we assessed the relative predictive value of




We used 3 data sets to perform this analysis. We used the
100% Medicare Provider Analysis and Review File from
2011 to 2013 to identify the patient cohort, clinical data,
and outcomes of interest. We also used publically avail-
able 2016 Hospital Compare data to identify hospital star
rankings and the American Hospital Association annual
survey to evaluate hospital characteristics.
Study Population
Our study population included Medicare beneficiaries
aged 66 to 99 years who underwent a major extirpative
surgery for colorectal, prostate, bladder, esophageal, kid-
ney, liver, lung, ovarian, or pancreatic cancer from Janu-
ary 1, 2011 through November 30, 2013. Because we
wanted to answer the question of whether a typical patient
could use the Hospital Compare star rating system to
choose a hospital for major cancer surgery, we excluded
patients on the basis of 2 criteria. First, because they repre-
sent more complex operations with inherently different
outcomes, we excluded patients who had 2 or more
different oncologic procedures on the same day. Second,
because patients with synchronous malignancies or staged
procedures are also often more complex cases and may
be served only by select centers with the appropriate
resources, we excluded those who had more than 1
procedure 180 days apart. Finally, to improve statistical
reliability, we also excluded hospitals with fewer than 10
oncologic procedures during the period of interest. These
exclusions accounted for only 1.7% of the entire patient
cohort (n5 6504). Finally, we excluded patients who
received surgery at a hospital that lacked CMS star
ratings.
Exposure Variables
For each patient, we first identified the hospital at which
the patient had the extirpative cancer surgery. We then
determined the CMS star rating (ie, 1, 2, 3, 4, or 5 stars)
and average annual cancer surgery volume for the hospital
where the surgery occurred. The star rating is a composite
score comprising 64 possible measures that are currently
part of the CMS Hospital Compare program. The indi-
vidual measures are assigned to 7 different categories:
mortality, safety, readmissions, patient experience, care
effectiveness, care timeliness, and efficient use of medical
imaging. To receive a star rating, a hospital has to report a
minimum of 3 measures in at least 3 categories, including
1 of the outcome categories (mortality, safety, and read-
missions). The CMS calculates a hospital’s star rating
with only the measures that the hospital chooses to report.
The rating is publically available as part of the CMS Hos-
pital Compare program.11
For each hospital, we assigned cancer surgery vol-
ume on the basis of the cumulative number of cases for all
9 cancers included in our analysis (bladder, colon, esopha-
geal, kidney, liver, lung, ovarian, pancreatic, and prostate
cancer) averaged over the 3 years of data in our cohort.
We classified hospitals into quintiles on the basis of this
volume measure (with 1 representing the lowest volume
and 5 representing the highest volume), and we assigned
patients to the volume quintile of their treating hospital.
We used the overall cancer surgery volume for these analy-
ses rather than individual procedure volumes because we
believe that this composite measure reflects the most
policy-relevant volume metric and one that could be con-
sidered reasonably analogous to the composite star ratings
available fromHospital Compare.
Outcome Measures
We measured 4 outcomes occurring within 30 days of the
index cancer surgery: mortality, complications, prolonged
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length of stay, and hospital readmissions. Complications
were defined with established methods12-14 and included
infections, bleeding, gastrointestinal complications, neu-
rologic complications, pulmonary complications, renal
complications, cardiac complications, and other compli-
cations. A prolonged length of stay was defined as a hospi-
tal stay exceeding the 90th percentile for an individual
procedure.15
Statistical Analysis
We first performed univariate statistical analyses to com-
pare patient and hospital characteristics across star rating
categories and surgical volume strata. We also used uni-
variate statistical tests to evaluate the relationship between
hospital star ratings and cancer surgery volume quintiles.
Next, we examined the association between cancer
surgery outcomes and both star ratings and surgical vol-
umes. To do this, we fit multilevel logistic regression
models and controlled for both patient characteristics
(age, sex, race, and Elixhauser comorbidities) and hospital
characteristics (hospital bed number, urban location vs
rural location, region, and teaching status).
We then used a graphical approach to compare how
well star ratings and surgical volumes predict cancer sur-
gery outcomes. We show how the outcomes compare not
only across star ratings and volume quintiles but also
across hospitals ranked into quintiles by the 4 cancer sur-
gery outcomes. If the star ratings or surgical volumes pre-
dict cancer surgery outcomes, they will graphically show
patterns similar to those for cancer surgery outcomes.
To do this, we first divided hospitals into quintiles
based on their actual performance with each outcome
measure. For example, a new hospital mortality rate quin-
tile variable was created from the actual mortality rates for
individual hospitals. By definition, this new measure rep-
resents the greatest possible relationship that could be
attained between the outcome and any measurement rat-
ing system restricted to 5 quintiles and a linear line (eg,
star rating or surgical volume); necessarily, therefore, this
relationship represents a gold standard for comparing
other hospital performance measures. Graphically, the
slope of the line that is closest to the slope for the outcome
measurement represents the better measure for predicting
the outcome. A horizontal line would represent no associ-
ation between the measurement strata and outcome
(R25 0).
We repeated this analysis for the star rating and sur-
gical volume measurement categories for each cancer sur-
gery outcome. That is, we calculated the mean hospital
outcome by the rating quintile, fit the best line through
the means, and calculated the slope of the line. The mea-
surement (surgical volume or star rating) with the steeper
relative slope represents the measurement that, on aver-
age, better predicts the outcome.
Finally, we performed several sensitivity analyses to
examine the robustness of our findings. To analyze case-
mix differences, we calculated the share of high-risk
patients (>2 comorbidities) and low-risk patients (2
comorbidities) in hospitals across star ratings; we com-
puted the percent share of each cancer type that contrib-
uted to a hospital’s total cancer surgery volume and
compared this percent share across star ratings; and we
performed our primary analyses at the hospital level,
which weighted each hospital’s cancer specific outcome
measures by the representative share of that cancer in our
national sample. Second, to evaluate whether small num-
bers of procedures altered our findings, we repeated our
primary analyses with hospitals limited to those with the
highest cancer surgery volume (the top 50% and 75%).
Third, we examined outcome stability over time. Fourth,
to evaluate the impact of reporting patterns on star rat-
ings, we compared the number of measurement categories
that each hospital reported to the Hospital Compare pro-
gram across star ratings, and we stratified outcomes by the
number of reported measures among 5-star hospitals.
Fifth, to evaluate whether our findings were clinically rele-
vant in addition to policy-relevant, we measured the cor-
relation between the overall cancer surgery volume
quintile and the cancer-specific surgical volume quintile.
All analyses were performed with Stata 14 (Stata-
Corp LP, College Station, Texas) at the 5% significance
level. The University of Michigan institutional review
board deemed this study exempt from review.
RESULTS
We identified 384,519 patients who underwent major
cancer surgery for 1 of 9 cancers at 2667 hospitals in the
United States. In this group, 365,752 patients were
treated at 2550 hospitals that were assigned a star rating in
Hospital Compare. Overall, 5% of the hospitals were
assigned a 1-star rating, 24% were assigned 2 stars, 44%
were assigned 3 stars, 25% were assigned 4 stars, and 3%
were assigned 5 stars. The median annual cancer surgery
surgical volume for each volume quintile was 5.0, 11.3,
22.1, 43.7, and 98.3, respectively.
Table 1 presents differences in patient characteristics
according to star rankings and volume quintiles. As illus-
trated in Figure 1, the star rating had little to no associa-
tion with surgical volume. Illustrating this point, 24% of
the 5-star hospitals were high-volume hospitals, whereas
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TABLE 1. Patient and Hospital Characteristics by the Centers for Medicare and Medicaid Services’ Hospital
Compare Star Rating and Surgical Volume Quintile
Characteristic
Star Rating
P1 (Lowest) 2 3 4 5 (Highest)
Patients
Age, mean, y 74.4 74.5 74.5 74.5 74.5 0.033
Male sex, % 56.5 57.9 57.5 58.4 62.2 <.001
Race, % <.001
White 75.0 84.5 87.2 88.9 90.0
African American 17.5 10.6 7.4 5.8 5.1
Other 7.5 4.9 5.5 5.3 4.8
No. of comorbidities, % <.001
0 9.9 9.6 10.0 10.5 12.4
1 20.1 20.9 21.0 21.5 22.0
2 23.0 22.9 22.6 22.4 22.8
3 18.6 18.8 18.4 17.8 17.4
4 28.4 27.9 28.0 27.8 25.4
Hospitals
Geographic region, % <.001
Northeast 39.7 23.3 15.4 13.1 6.4
Midwest 11.6 15.5 24.8 40.0 42.9
South 31.4 43.0 38.0 28.2 33.3
West 17.4 18.1 21.8 18.7 17.5
No. of beds, % .302
<200 81.0 75.6 80.3 76.4 71.4
200-399 13.2 14.8 11.7 14.2 15.9
400-599 3.3 4.9 4.8 6.1 4.8
600 2.5 4.7 3.3 3.4 7.9
Hospital profit status, % <.001
For profit 18.2 21.1 18.5 10.5 14.3
Nonprofit 50.4 64.3 69.4 78.2 77.8
Public 31.4 14.6 12.2 11.3 7.9
Teaching hospital, % 59.5 41.8 30.7 30.0 33.3 <.001
Urban location, % 87.6 79.1 67.1 73.2 81.0 <.001
Characteristic
Surgical Volume Quintile
P1 (Lowest) 2 3 4 5 (Highest)
Patients
Age, mean, y 77.1 76.3 75.5 74.8 74.0 <.001
Male sex, % 48.3 51.1 53.9 56.5 60.1 <.001
Race, % <.001
White 86.5 85.7 84.9 86.5 86.9
African American 7.9 9.1 9.2 8.0 7.9
Other 5.6 5.2 5.9 5.5 5.2
No. of comorbidities, % <.001
0 6.7 7.3 7.6 9.0 11.3
1 16.2 16.6 17.7 19.8 22.6
2 21.5 21.1 21.6 22.2 23.2
3 19.6 19.3 19.3 18.5 17.9
4 35.9 35.6 33.8 30.5 25.0
Hospitals
Geographic region, % .025
Northeast 12.4 19.1 19.0 19.7 17.5
Midwest 32.2 26.0 25.2 23.8 24.2
South 36.1 36.9 36.4 43.2 38.0
West 19.4 18.0 19.4 22.4 20.3
No. of beds, % <.001
<200 100.0 100.0 100.0 83.9 6.1
200-399 0.0 0.0 0.0 16.1 50.0
400-599 0.0 0.0 0.0 0.0 25.4
600 0.0 0.0 0.0 0.0 18.5
Hospital profit status, % <.001
For profit 22.0 18.6 22.4 13.2 8.9
Nonprofit 58.0 66.4 64.8 76.0 83.3
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16% of the 1-star hospitals were in the highest quintile for
overall cancer surgery volume (P< .001).
Across all hospitals and all procedures, the average
frequencies of our measured 30-day outcomes were as fol-
lows: 3.4% for mortality, 43.7% for complications,
12.3% for readmissions, and 10.3% for a prolonged
length of stay. In univariate and multivariate analyses,
both the Hospital Compare star ratings and the surgical
volume quintiles were inversely associated with the occur-
rence of each short-term cancer surgery outcome (Table 2
and Fig. 2). After we controlled for patient and hospital
characteristics, 5-star hospitals had a 2.3% mortality rate,
whereas 1-star hospitals had a 4.5% rate; the complication
rates were 39% and 48% (P< .001), the readmission rates
were 10% and 15% (P< .001), and the rates for a pro-
longed length of stay were 8% and 16% (P< .001) for 5-
and 1-star hospitals, respectively. With respect to the sur-
gical volume, the average mortality rates were 2.7% and
5.8% for the highest and lowest volume hospitals, respec-
tively (P< .001); the rates of complications were 41%
and 55% (P< .001), the readmission rates were 12.2%
and 11.6% (P5 .195), and the rates for a prolonged
length of stay were 9.4% and 13% (P< .001) for hospitals
in the highest and lowest quintiles, respectively (Table 2).
Figure 3 presents a comparison of the performance
of star ratings and surgical volumes for predicting each of
the cancer surgery outcomes. For 30-day mortality, the
line fit to actual mortality quintiles has a slope of –2.48.
This contrasts with slopes of –0.58 for the star rating and –
0.73 for surgical volume. This, therefore, suggests that, on
average, surgical volume and the star rating are similarly
associated with themortality rate.We observed a compara-
ble relationship for the complication rate (Fig. 3). This is
in contrast to the slopes for the readmission rate and a pro-
longed length of stay, which suggest a stronger relationship
with the star rating than the surgical volume.
Our sensitivity analyses identified no substantive
changes to our principal findings. In our examination of
hospital reporting and star ratings, 95% of the hospitals
reported either 6 or 7 measures, and there was a similar




P1 (Lowest) 2 3 4 5 (Highest)
Public 20.0 15.1 12.8 10.8 7.9
Teaching hospital, % 15.1 18.0 28.8 39.9 71.1 <.001
Urban location, % 37.3 58.7 78.2 91.9 97.6 <.001
Figure 1. Relationship between the Centers for Medicare and
Medicaid Services’ Hospital Compare star rating and the
average annual major cancer surgery volume among hospi-
tals in the United States.
TABLE 2. Unadjusted Overall Cancer Surgery
Outcomes by the Centers for Medicare and
Medicaid Services’ Hospital Compare Star Rating
and Surgical Volume Quintile
Outcome
Star Rating
P1 (Lowest) 2 3 4 5 (Highest)
30-day mortality rate 4.4 3.7 3.5 3.0 2.3 <.001
30-day complication
rate
47.1 44.5 43.6 43.1 39.3 <.001
30-day readmissions 14.5 13.2 12.1 11.6 10.3 <.001
Prolonged length
of stay
14.7 11.7 10.0 8.9 7.7 <.001
Outcome
Surgical Volume Quintile
P1 (Lowest) 2 3 4 5 (Highest)
30-day mortality rate 5.8 5.6 4.8 4.0 2.7 <.001
30-day complication
rate
55.0 52.8 49.7 45.9 40.7 <.001
30-day readmissions 11.6 13.0 12.4 12.2 12.3 .018
Prolonged length
of stay
13.1 13.6 12.6 11.1 9.2 <.001
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the full 7 measures (89% for 1-star hospitals vs 84% for 5-
star hospitals). Among 5-star hospitals, the mean mortal-
ity rate, complication rate, and prolonged-length-of-stay
rate were highest for those reporting 3 outcome measures
(the maximum allowable). Readmission rates were highest
among hospitals reporting 2 outcome measures. Lastly,
our analysis of the correlation between the overall cancer
surgery volume and the cancer-specific volume demon-
strated that the cancer-specific volume was at least moder-
ately correlated with the overall cancer surgery volume for
7 of 9 cancers (Supporting Table 1 [see online supporting
information]).
DISCUSSION
Across a national sample of hospitals in the United States,
we observed no association between CMS’ Hospital Com-
pare star ratings and annual cancer surgery volumes. How-
ever, both higher star ratings and larger surgical volumes
were associated with better short-term cancer surgery out-
comes, including lower rates of mortality, complications,
Figure 2. Adjusted overall cancer surgery outcomes by (A) the Centers for Medicare and Medicaid Services’ Hospital Compare
star rating and (B) surgical volume quintile.
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readmissions, and prolonged length of stay. On average,
the surgical volume and the star rating were similarly asso-
ciated with mortality and complication rates, whereas the
star rating had a stronger relationship with readmissions
and a prolonged length of stay. Collectively, these findings
suggest that in the absence of other information, the star
rating may be useful in helping patients to select a hospital
for major cancer surgery, but more research is needed
before these ratings can supplant surgical volume as a
measure of surgical quality.
Our findings are consistent with previous work that
has convincingly demonstrated a strong association between
higher surgical volumes and better short- and long-term out-
comes after major cancer surgery.16-19 Importantly, how-
ever, our observation that there is little, if any, correlation
between the star rating and surgical volume for cancer sur-
gery indicates that the Hospital Compare measure cannot
be used as a publically available proxy for case volume. In
other words, choosing a hospital with a high star rating does
not mean that a patient is selecting a high-volume facility.
At the same time, we also identified a significant
inverse association between hospital star ratings and
short-term cancer surgery outcomes. This is a new finding
and, in many ways, is discordant with previous literature
demonstrating inconsistencies among differing public
reporting systems.9 Moreover, despite the potentially
important implications of this finding for patients seeking
cancer care, many have criticized the methodology used
to create the star ranking as both flawed and excessively
opaque.2,20-22
In this context, there are several potential reasons for
the observed association between star ratings and short-
term cancer surgery outcomes that need to be addressed
before star ratings can supplant surgical volume as a mea-
sure of surgical quality. Included among these is the possi-
bility that star rankings will prove to be an accurate
measure of hospital performance with major cancer sur-
gery. However, alternative explanations must also be con-
sidered. Although we controlled for measurable patient
comorbidities and carefully assessed case-mix differences
between the hospitals, it remains possible that the
observed association reflects residual unmeasured differ-
ences in cancer severity or comorbidity among patients in
the different star rating categories. Our finding could also
Figure 3. Comparison of goodness-of-fit lines for the Centers for Medicare and Medicaid Services’ Hospital Compare star rating
and cancer surgery volume with respect to actual measured outcomes.
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reflect a tautological relation (ie, a finding that is true
because of the way it was conceived) to the extent that
some of the outcomes that we measured (eg, readmis-
sions) are also used to assign star ratings in the first place.
Although it is difficult to empirically examine this con-
cern, it is worth noting that the Hospital Compare meth-
odology does not include any cancer-specific quality
measures. Instead, the Hospital Compare methodology
predominantly reflects outcomes, processes, and satisfac-
tion with care for cardiac and pulmonary disease and
stroke. In fact, only 9 of 64 possible measures contribut-
ing to the star ratings could directly apply to patients
undergoing major cancer surgery, and the majority would
be demonstrated in our complication outcome.
Finally, the observed association could also reflect
the effect of hospitals with small case numbers or hospitals
that gamed the star rating system by reporting fewer mea-
sures.2 Although valid, these concerns are mitigated by
findings from our sensitivity analyses demonstrating no
differences in our findings after we had excluded hospitals
with low surgical volumes as well as the findings that 95%
of hospitals reported 6 or 7 measures and that the propor-
tion of hospitals reporting on all 7 measures was similar
across rating categories (89% for 1-star hospitals vs 84%
for 5-star hospitals). Moreover, among hospitals with a 5-
star rating, those reporting the maximum number of out-
come measures3 had higher mortality rates, higher com-
plication rates, and increased lengths of stay in
comparison with those reporting fewer measures, and this
is counter to the argument that gaming is occurring.
Our study has several limitations. First, we examined
only short-term cancer surgery outcomes for 9 types of
cancer. As a result, our findings may not apply for other
outcomes and tumors. That being said, the cancer sites
included in our analysis compose approximately 46% of
the estimated newly diagnosed invasive cancers in 2016 in
the United States.23 Second, although we are equating the
outcomes measured in this analysis with quality of care for
cancer surgery, there are obviously many other measures
that could be considered, including longer term or
patient-reported outcome measures. It is also true, how-
ever, that the outcomes assessed herein can be defined and
measured accurately with claims data, and they are widely
used to measure and compare surgical quality. Third, the
care delivered occurred before the star rating. However,
the CMS devised the star rating system on the basis of pre-
vious years’ measures, and our sensitivity analyses demon-
strated that outcomes did not vary over time. Fourth,
although we excluded some patients undergoing cancer
surgery to increase generalizability and statistical
reliability, this step may have resulted in a biased sample.
However, because of the very small proportion of cases
(1.7% of the total sample) affected by our exclusion crite-
ria, the implications for our overall findings are likely lim-
ited. Last, we used overall surgical volume when one
could argue that the more clinically relevant measure is
cancer-specific volume. Nonetheless, we selected overall
volume because it is more consistent with evaluating the
hospital as a whole and is comparable to the Hospital
Compare 5-star system. Furthermore, our sensitivity anal-
ysis indicated that cancer-specific volumes correlated
fairly well with overall cancer surgery volumes.
These limitations notwithstanding, our findings
have important implications for patients, policymakers,
payers, and hospital administrators. For patients, our
analyses support using surgical volume, when available, as
a guide for choosing where to have major cancer surgery.
Our findings also suggest a potential role for the Hospital
Compare star rankings; however, because of the prelimi-
nary nature of this measure, surgical volume currently
remains a more acceptable metric of a hospital’s average
short- and long-term cancer surgery outcomes.
For CMS policymakers, our findings do suggest that
star ratings may capture real differences between hospitals
for cancer surgery outcomes. Nevertheless, important ques-
tions still remain about how hospitals get into one category
versus another, about the opacity of the measurement meth-
odology, and about the extent to which reporting differences
influence a hospital’s rating. Thus, although our findings do
provide support for additional assessment of these measures,
several concerns must be addressed before the star rating can
be viewed as an actionable and reliable measure of quality.
An important next step would be to analyze how the mea-
sure performs for disease states (eg, gastrointestinal bleeds)
that are far removed from the conditions contributing to the
measure. Finally, because our findings suggest that star rank-
ings may have some validity as a hospital quality measure,
hospital administrators may view these results as an addi-
tional motivation to measure and improve performance on
the various processes and outcomes that collectively yield the
Hospital Compare star measure.
In the future, additional research needs to be per-
formed on case-mix differences, tautology, reporting bias,
and other procedures and diagnoses. It will also be impor-
tant to examine the stability of this measure over time and
its relationship with other measures of cancer care quality.
Thus, although the Hospital Compare star rating appears
to be associated with short-term cancer surgery outcomes,
more evaluation is required before it can be used to make
selecting a hospital for cancer surgery any easier.
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